Skip to content
HowShorted

TherapeuticsMD, Inc. short interest in 2024

In 2024, TherapeuticsMD, Inc.'s disclosed short interest ran from 1.23% of shares outstanding on 12 Jan 2024 to 0.79% on 13 Sep 2024, a change of -0.44 percentage points. The year's high was 1.23% on 12 Jan 2024 and its low 0.29% on 14 Jun 2024, averaging 0.53% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.55 days on 13 Sep 2024. Full history: TherapeuticsMD, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TherapeuticsMD, Inc. in 2024

2024 in figures

Start of year
1.23% (12 Jan 2024)
End of year
0.79% (13 Sep 2024)
Change
-0.44 pp
High
1.23% (12 Jan 2024)
Low
0.29% (14 Jun 2024)
Average
0.53%
Highest days to cover
8.55 (13 Sep 2024)
SEC filings marked
8

Every report in 2024

TherapeuticsMD, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20241.23%8.37
31 Jan 20240.52%3.65
15 Feb 20240.48%4.84
29 Feb 20240.39%2.24
15 Mar 20240.45%1.48
28 Mar 20240.39%2.27
15 Apr 20240.40%1.2810-K filed, results (8-K)
30 Apr 20240.44%2.70
15 May 20240.34%3.1510-Q filed, results (8-K)
31 May 20240.32%2.99
14 Jun 20240.29%2.78
28 Jun 20240.46%2.05
15 Jul 20240.37%1.76
31 Jul 20240.36%5.02
15 Aug 20240.98%6.5010-Q filed, results (8-K)
30 Aug 20240.86%6.01
13 Sep 20240.79%8.55

See also: TherapeuticsMD, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.